Naturex's revenue for the first nine months of fiscal 2013 rose 8.7% from a year ago, or 10.9% at constant exchange rates, to €242.6 million.
In the latest earnings update, the company revealed the results of its profits for the first nine months of fiscal 2013, reporting group net income of €13.7 million compared to €14.7 million for the first nine months of 2012, after a tax charge of €6.8 million (compared with €6.0 million at Sept. 30 2012).
As reported earlier, 8.6% of revenue growth came from organic growth and 2.3% from changes in group structure including synergies from Decas Botanical consolidated on Sept. 19, 2012.
Foreign exchange trends had a negative impact in the period, particularly in the 2013 third quarter, reflecting the depreciation of several currencies versus the euro including the U.S. and Australian dollars and selected emerging country currencies (Brazil, Mexico, China, Russia, India, etc.).
Food and beverage had sales of €141.6 million for the first nine months, up 1.6% at constant exchange rates. Nutrition and health, largely focused on the U.S. market, maintained strong growth with sales of €83.5 million, up 27.3% at constant exchange rates. Personal care, which represents 1.8% of group revenue, had sales of €4.3 million, up 21.6% at constant exchange rates for the first nine months of 2013.
All geographic regions delivered good growth, both in mature markets still affected by a difficult economic environment in Europe, and emerging markets with continuing momentum that accounted for 17.9% of group sales for the 2013 nine-month period and 21.1% for the 2013 third-quarter.